Clinical Trial Update: Study of Methylphenidate as Add on Therapy in Depressed Cancer Patients [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating methylphenidate as add-on therapy for depression in patients with cancer; the update provides no results or status detail…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Major Depressive Disorder

Drugs mentioned

• Methylphenidate (Methylphenidate)

Snippet

Sponsor: University of Malaya | Conditions: Depression | Phase 3 | Status: UNKNOWN